Ayala Pharmaceuticals Inc (AYLA)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 03-2020 | 12-2019 | 09-2019 | 06-2019 | 03-2019 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -6,598 | -17,792 | -12,369 | -7,322 | -3,539 |
| Depreciation Amortization | 53 | 150 | 47 | 28 | 20 |
| Accounts receivable | -532 | -469 | -660 | -149 | -265 |
| Accounts payable and accrued liabilities | 29 | 1,964 | 997 | 979 | 200 |
| Other Working Capital | -139 | 1,965 | 483 | 795 | -252 |
| Other Operating Activity | 796 | -768 | 246 | -435 | 274 |
| Operating Cash Flow | $-6,391 | $-14,950 | $-11,256 | $-6,104 | $-3,562 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -20 | -1,330 | -799 | -799 | -206 |
| Other Investing Activity | 202 | -251 | -139 | -139 | -112 |
| Investing Cash Flow | $182 | $-1,581 | $-938 | $-938 | $-318 |
| Cash Flows From Financing Activities | |||||
| Common Stock Issued | N/A | 4 | 4 | 4 | 4 |
| Other Financing Activity | -261 | 7,071 | 7,163 | 7,163 | 3,191 |
| Financing Cash Flow | $-261 | $7,075 | $7,167 | $7,167 | $3,195 |
| Beginning Cash Position | 16,808 | 26,264 | 26,097 | 26,097 | 26,097 |
| End Cash Position | 10,338 | 16,808 | 21,070 | 26,222 | 25,412 |
| Net Cash Flow | $-6,470 | $-9,456 | $-5,027 | $125 | $-685 |
| Free Cash Flow | |||||
| Operating Cash Flow | -6,391 | -14,950 | -11,256 | -6,104 | -3,562 |
| Capital Expenditure | -20 | -1,330 | -799 | -799 | -206 |
| Free Cash Flow | -6,411 | -16,280 | -12,055 | -6,903 | -3,768 |